C&R Research Inc. (KOSDAQ: 359090)
South Korea
· Delayed Price · Currency is KRW 1,281.00
-5.00 (-0.39%)
Oct 11, 2024, 9:00 AM KST
C&R Research Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2019 |
|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '19 Dec 31, 2019 |
| Revenue | 58,402 | 55,102 | 48,473 | 43,171 | 27,203 |
| Revenue Growth (YoY) | 15.39% | 13.68% | 12.28% | 58.70% | - |
| Gross Profit | 58,402 | 55,102 | 48,473 | 43,171 | 27,203 |
| Selling, General & Admin | 50,102 | 46,308 | 41,806 | 35,680 | 26,302 |
| Other Operating Expenses | 1,469 | 1,417 | 1,217 | 996.8 | 651.79 |
| Operating Expenses | 52,741 | 48,869 | 43,673 | 37,420 | 27,494 |
| Operating Income | 5,660 | 6,233 | 4,800 | 5,751 | -290.09 |
| Interest Expense | -340.65 | -393.73 | -380.95 | -511.01 | -854.38 |
| Interest & Investment Income | 350.17 | 330.52 | 246.16 | 5.22 | 3.03 |
| Earnings From Equity Investments | -692.91 | -438.58 | -407.44 | -397.13 | -348.74 |
| Currency Exchange Gain (Loss) | 70.4 | -17.65 | -12.57 | -55.56 | -2.23 |
| Other Non Operating Income (Expenses) | 254.93 | 7.51 | -1.56 | -7,517 | -4.42 |
| EBT Excluding Unusual Items | 5,302 | 5,721 | 4,244 | -2,724 | -1,497 |
| Gain (Loss) on Sale of Investments | - | - | - | - | -4.47 |
| Asset Writedown | 70 | 70 | -60.36 | - | - |
| Pretax Income | 5,372 | 5,791 | 4,183 | -2,724 | -1,501 |
| Income Tax Expense | 239.87 | 243.67 | 163.77 | 579.93 | 179.63 |
| Earnings From Continuing Operations | 5,133 | 5,547 | 4,019 | -3,304 | -1,681 |
| Earnings From Discontinued Operations | 13.04 | 13.04 | -91.86 | - | - |
| Net Income to Company | 5,146 | 5,560 | 3,928 | -3,304 | -1,681 |
| Minority Interest in Earnings | 15.46 | 2.58 | 1.15 | 3.47 | -1.37 |
| Net Income | 5,161 | 5,563 | 3,929 | -3,301 | -1,682 |
| Net Income to Common | 5,161 | 5,563 | 3,929 | -3,301 | -1,682 |
| Net Income Growth | 20.81% | 41.59% | - | - | - |
| Shares Outstanding (Basic) | 55 | 55 | 54 | 5 | 2 |
| Shares Outstanding (Diluted) | 57 | 56 | 54 | 5 | 2 |
| Shares Change (YoY) | 5.23% | 4.94% | 982.01% | 230.56% | - |
| EPS (Basic) | 93.53 | 101.88 | 73.23 | -665.67 | -1121.52 |
| EPS (Diluted) | 91.53 | 99.90 | 73.23 | -666.00 | -1121.52 |
| EPS Growth | 16.96% | 36.42% | - | - | - |
| Free Cash Flow | 6,850 | 3,319 | 1,651 | 1,002 | -49.17 |
| Free Cash Flow Per Share | 119.81 | 58.95 | 30.77 | 202.05 | -32.78 |
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Operating Margin | 9.69% | 11.31% | 9.90% | 13.32% | -1.07% |
| Profit Margin | 8.84% | 10.09% | 8.10% | -7.65% | -6.18% |
| Free Cash Flow Margin | 11.73% | 6.02% | 3.41% | 2.32% | -0.18% |
| EBITDA | 6,831 | 7,377 | 5,450 | 6,435 | 250.12 |
| EBITDA Margin | 11.70% | 13.39% | 11.24% | 14.91% | 0.92% |
| D&A For EBITDA | 1,171 | 1,145 | 649.67 | 683.56 | 540.21 |
| EBIT | 5,660 | 6,233 | 4,800 | 5,751 | -290.09 |
| EBIT Margin | 9.69% | 11.31% | 9.90% | 13.32% | -1.07% |
| Effective Tax Rate | 4.46% | 4.21% | 3.91% | - | - |
Source: S&P Capital IQ. Standard template. Financial Sources.